OpenVSafe by OpenVAERS
Search V-safe

24U-37277-27136

4 vaccinations 7 coded responses 39 check-ins 8 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
350 / AL
Registered
2021-02-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-10
    Registered in v-safe
  2. 2021-02-10
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-10
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Nausea, Diarrhea
    Adult check-in
  5. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-17
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-03
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-03
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Diarrhea · Be unable to work
    Adult check-in
  15. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  16. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Swelling, Itching · None
    Adult check-in
  17. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Swelling · None
    Adult check-in
  18. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  20. 2021-03-10
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  21. 2021-03-17
    Survey response — day 14, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph nodes under left arm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-07
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-14
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-02
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-06-02
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-06-10
  29. 2021-09-01
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  30. 2021-10-10
    Dose 3 — Pfizer-BioNTech
  31. 2022-03-03
    Survey response — 12 months, dose 2
    MedDRA: Deafness unilateral, Meniere's disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lost hearing in left ear; diagnosed with Meniere's; no previous ear/hearing issues
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-03-03
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2022-03-04
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  34. 2022-04-10
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-10-10
    Survey response — 12 months, dose 3
    MedDRA: Diabetes mellitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: New onset diabetes
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-10-10
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2022-10-11
  38. 2022-12-11
    Dose 4 — Pfizer-BioNTech
  39. 2022-12-11
    Health check-in — day 0, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-12-12
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fever · Fatigue or tiredness
    Adult check-in
  41. 2022-12-13
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  42. 2022-12-14
    Survey response — days 1–6 daily, dose 4
    MedDRA: Blood glucose increased — Feeling: Poor · Muscle or body aches, Fatigue or tiredness
    Free text: High blood glucose
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-12-15
    Survey response — days 1–6 daily, dose 4
    MedDRA: Blood glucose increased — Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Free text: High blood glucose levels
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-12-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Blood glucose increased — Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: High blood glucose
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-12-18
    Health check-in — day 7, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  46. 2022-12-25
    Health check-in — day 14, dose 4
    Feeling: Poor · Be unable to do your normal daily activities
    Free text: Urinary urgency
    Adult check-in · check-in free text available
  47. 2023-01-01
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  48. 2023-01-08
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  49. 2023-01-22
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  50. 2023-03-12
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-10Pfizer-BioNTech
22021-03-03Pfizer-BioNTech
32021-10-10Pfizer-BioNTech No
42022-12-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-06-02 Successful Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-03-03 Successful
2022-03-04
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-10-10 Unsuccessful

Free text

Release 5 — day 14, dose 2

2021-03-17

Symptoms: Swollen lymph nodes under left arm

Release 8 — 3 months, dose 2

2021-06-02

Symptoms: Shortness of breath

Release 11 — 12 months, dose 2

2022-03-03

Symptoms: Lost hearing in left ear; diagnosed with Meniere's; no previous ear/hearing issues

Release 12 — 12 months, dose 3

2022-10-10

Symptoms: New onset diabetes

Release 12 — days 1–6 daily, dose 4

2022-12-14

Systemic reaction (other): High blood glucose

2022-12-15

Systemic reaction (other): High blood glucose levels

2022-12-17

Systemic reaction (other): High blood glucose

Release 12 — day 14, dose 4

2022-12-25

Symptoms: Urinary urgency

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDeafness unilateral · · ✓
SDDiabetes mellitus · · ✓
SDDyspnoea ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMeniere's disease · · ✓
SROBlood glucose increased · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release